Vitalhub (TSE:VHI) Trading Up 0.4% - Should You Buy?

Key Points

• Price and trading: Vitalhub traded up 0.4% to C$8.03 on light volume (≈175,448 shares, down ~55% vs. average), with a market cap of C$507.8M, a P/E of 80.3, 50‑day/200‑day SMAs of C$7.70/C$8.69, and last quarter EPS of C$0.06 on C$31.39M revenue.
• Analyst outlook: Several analysts cut target prices but still rate the stock positively, leaving a MarketBeat consensus rating of "Buy" and a consensus target price of C$13.86.
• Insider buying: Company insiders acquired 496,600 shares in the past three months (including recent director purchases), and insiders now own about 18.57% of the shares outstanding.

Vitalhub Corp. (TSE:VHI - Get Free Report) was up 0.4% on Monday . The company traded as high as C$8.20 and last traded at C$8.03. Approximately 175,448 shares changed hands during mid-day trading, a decline of 55% from the average daily volume of 388,108 shares. The stock had previously closed at C$8.00.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on VHI shares. Raymond James Financial cut their price target on Vitalhub from C$15.00 to C$11.00 and set an "outperform" rating for the company in a report on Tuesday, March 24th. Scotiabank dropped their target price on Vitalhub from C$15.00 to C$12.00 and set an "outperform" rating for the company in a research note on Wednesday, February 4th. Royal Bank Of Canada dropped their target price on Vitalhub from C$13.00 to C$12.00 and set an "outperform" rating for the company in a research note on Monday, January 26th. Finally, ATB Cormark Capital Markets dropped their target price on Vitalhub from C$16.50 to C$15.00 and set an "outperform" rating for the company in a research note on Tuesday, March 10th. One analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of C$13.86.

Vitalhub Price Performance

The stock has a 50-day simple moving average of C$7.70 and a 200-day simple moving average of C$8.69. The stock has a market cap of C$507.75 million, a PE ratio of 80.30, a P/E/G ratio of 1.18 and a beta of 0.87.

Vitalhub (TSE:VHI - Get Free Report) last posted its quarterly earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share (EPS) for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%.The firm had revenue of C$31.39 million during the quarter. As a group, equities research analysts anticipate that Vitalhub Corp. will post 0.2296467 EPS for the current year.

Insider Transactions at Vitalhub

In other news, Director Anthony Pius Shen purchased 7,000 shares of the stock in a transaction on Monday, March 30th. The stock was purchased at an average price of C$7.11 per share, with a total value of C$49,770.00. Following the completion of the transaction, the director owned 12,470 shares in the company, valued at approximately C$88,661.70. The trade was a 127.97% increase in their ownership of the stock. Also, Director Francis Nelson Shen purchased 50,000 shares of the stock in a transaction on Thursday, March 26th. The shares were purchased at an average cost of C$6.99 per share, with a total value of C$349,500.00. Following the transaction, the director owned 50,000 shares of the company's stock, valued at C$349,500. This trade represents a ∞ increase in their position. In the last three months, insiders have acquired 496,600 shares of company stock valued at $3,476,470. 18.57% of the stock is owned by company insiders.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.